DIABETES MELLITUS
Diabetes mellitus (see Chapter
27
) is the most common endocrine disease and is characterized by long-term
complications involving the eyes, kidneys, nerves, and
TABLE 46-16 -- Classification of diabetes
Class |
Causes and Characteristics |
Primary |
Insulin-dependent diabetes mellitus (IDDM, type 1: without insulin
the patient will develop ketoacidosis and die) |
|
Non-insulin-dependent diabetes mellitus (NIDDM, type 2: the
patient will not necessarily develop ketoacidosis without insulin) |
|
Nonobese NIDDM (type 1 IDDM in evolution?) |
|
Obese NIDDM |
|
Maturity-onset diabetes of the young |
Secondary |
Pancreatic disease, hormonal abnormalities, drug or chemical
induced, insulin receptor abnormalities, genetic syndrome, other |
Adapted from Foster DW: Diabetes mellitus. In
Isselbacher KJ, Braunwald E, Wilson JD, et al (eds): Harrison's Principles of Internal
Medicine, 13th ed. New York, McGraw-Hill, 1995, p 1980. |
blood vessels. Diabetes is a major risk factor for heart disease, stroke, kidney
disease, blindness, and nontraumatic amputations. The cause of diabetic complications
is multifactorial, including glycosylation of proteins and glucose reduction to sorbitol,
which functions as a tissue toxin. This pathophysiologic process is associated with
a decrease in myoinositol content and metabolism and with a decrease in sodium-potassium-adenosine
triphosphatase activity. Hyperglycemia has been recognized as a major factor in
the development of complications associated with diabetes. The patient population
is not homogeneous, and several diabetic syndromes have been delineated. There are
almost 8 million diagnosed diabetics in the United States and another 8 million who
are unaware of their diabetes. These numbers approach 10% of the overall population
in this country[69]
( Table
46-16
).
Pathology
Hyperglycemia of diabetes is the consequence of relative or absolute
deficiency of insulin and a relative or absolute excess of glucagon. In type 1 diabetes,
there is an absolute deficiency in insulin production, and without insulin, patients
die. These patients eventually become dependent on exogenous insulin to prevent
lipolysis and eventually ketoacidosis. The onset of type 1 diabetes usually occurs
by adolescence, although it may occur at any age and is thought to result from autoimmune
destruction of islet cells in the pancreas.
Type 2 diabetes is characterized by a relative deficiency in insulin,
typically caused by insulin resistance. The onset of this type of diabetes is usually
in adulthood, although evidence suggests that the mean age of onset of type 2 diabetes
is decreasing.[70]
Type 2 diabetes almost certainly
has a heterogeneous group of etiologic factors. However, commonly associated findings
in type 2 diabetes are obesity, abnormal insulin levels, and a strong genetic component
[71]
( Table
46-17
).
A third type of diabetes mellitus is gestational diabetes. Gestational
diabetes is defined as any degree of glucose intolerance with the onset first recognized
during pregnancy. Gestational diabetes complicates approximately 4% of all pregnancies
in the United States, resulting in about 135,000 cases annually.[72]
Clinical recognition of gestational diabetes is important because therapy and
TABLE 46-17 -- Characteristics of type 1 and type 2 diabetes mellitus
Characteristic |
Type 1 |
Type 2 |
Genetic locus |
Chromosome 5 |
Chromosome 11 (?) |
Age of onset |
<40 |
>40 |
Body habitus |
Normal to wasted |
Obese |
Plasma insulin |
Low to absent |
Normal to high |
Plasma glucagons |
High, suppressible |
High, resistant |
Acute complications |
Ketoacidosis |
Hyperosmolar coma |
Insulin therapy |
Responsive |
Responsive to resistant |
Sulfonylurea therapy |
Unresponsive |
Responsive |
Foster DW: Endocrinology and metabolism. In
Wilson JD, Braunwald E, Fauci AS, et al (eds): Harrison's Principles of Internal
Medicine, 12th ed. New York, McGraw-Hill, 1991, p 1743. |
antepartum fetal monitoring can reduce perinatal morbidity and mortality. Maternal
complications related to gestational diabetes include an increased rate of cesarean
delivery.
During the past decade, a new disorder known as syndrome X has
been described. As the name implies, it is a syndrome rather than a specific disease
state. The hallmark of syndrome X is insulin resistance with hyperinsulinemia.
The underlying pathology is similar to type 2 diabetes; however, syndrome X patients
do not exhibit hyperglycemia. Syndrome X patients may never develop type 2 diabetes.
The clinical significance of this condition stems from its association with multiple
metabolic abnormalities, including low levels of high-density lipoprotein (HDL),
increased blood pressure, and increased plasminogen activator inhibitor-1 levels.
All these abnormalities have definite or possible association with coronary artery
disease. Whether syndrome X and type 2 diabetes are on a spectrum of disease with
insulin resistance as a common denominator or are totally separate entities has yet
to be clarified.